Wednesday, May 22, 2024
Home Tags Alzheimer’s disease program

Tag: Alzheimer’s disease program

Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease...

Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...